Search results
Results from the WOW.Com Content Network
Levetiracetam, sold under the brand name Keppra among others, is a novel antiepileptic drug [7] used to treat epilepsy. [8] It is used for partial-onset , myoclonic , or tonic–clonic seizures, [ 7 ] and is taken either by mouth as an immediate or extended release formulation or by injection into a vein .
Pivotal Phase III trials assess whether a candidate drug has efficacy specifically against a disease, and – in the case of people hospitalized with severe COVID-19 infections – test for an effective dose level of the repurposed or new drug candidate to improve the illness (primarily pneumonia) from COVID-19 infection.
Screening all students every two days with a "low-sensitivity, high-specificity test" (such as a RAT) would be able to control an outbreak of COVID-19. [12] Mina et al theorized that higher-frequency screening using lower-sensitivity RATs may be more useful than lower-frequency screening using higher-sensitivity PCR tests because the former ...
The quest for a COVID-19 vaccine reached an important juncture Monday as Moderna Therapeutics began the first phase 3 trial of a COVID-19 vaccine candidate in the U.S. Phase 3 is the final phase ...
The coronavirus crisis is putting new pressure on big pharma to contain price inflation related to potential treatments and vaccines. Gilead's breakthrough coronavirus drug sparks concerns over ...
Despite conflicting reports over the success of remdesivir, the NIH's Dr. Anthony Fauci says there's proof the drug can block the coronavirus. 'Clear-cut' evidence coronavirus drug remdesivir ...
COVID-19 Antigen Rapid Test Kit; the timer is provided by the user. Mucus from nose or throat in a test liquid is placed onto a COVID-19 rapid antigen diagnostic test device. COVID-19 rapid testing in Rwanda. An antigen is the part of a pathogen that elicits an immune response. Antigen tests look for antigen proteins from the viral surface.
Ensitrelvir is being studied for its potential use as post-exposure prophylaxis (PEP) after SARS-CoV-2 exposure. [19] [20] The SCORPIO-PEP trial is a global Phase 3 trial that will evaluate the safety and efficacy of the drug in preventing symptomatic SARS-CoV-2 infection in household contacts of people who tested positive for COVID-19.